Skip to content

Effects of Moxibustion on Gastrointestinal Cancer-Related Fatigue: A Randomized, Controlled Trial

Effects of Moxibustion on Gastrointestinal Cancer-Related Fatigue: A Randomized, Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006572
Enrollment
Unknown
Registered
2022-09-08
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancer-Related Fatigue

Interventions

Control group:placebo-moxibustion

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for gastric cancer and colorectal cancer, TNM staging is II to III; meet the diagnostic criteria for cancer-related fatigue(CRF), fatigue occurs after the diagnosis of gastric cancer and colorectal cancer, and is related to the cancer itself or cancer-related treatment; 2) Ages range from 18 to 70 years old; 3) ECOG score = 2 points; 4) BFI-C=4 points; 5) Estimated survival period = 6 months; 6) The patient has never received acupuncture or moxibustion within the first 3 months of enrollment; 7) No mental or intellectual abnormality, able to understand the provisions of various scales and complete the assessment; 8) Agree to participate in this study and sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1) Those who are highly suspected of malignant tumor but cannot find the primary tumor; 2) Suffering from major physical diseases, such as serious diseases of the heart, liver, kidney, etc.; 3) Life expectancy is less than 6 months, or bedridden; 4) Pregnant or lactating patients; 5) Symptomatic mental illness and mental disorders, patients who cannot communicate normally due to drug addiction, alcohol addiction, abuse of psychotropic substances, etc.; 6) There are ulcers, abscesses, skin infections, etc. at the moxibustion site; 7) Patients who have received moxibustion therapy due to fatigue in the past 1 month.

Design outcomes

Primary

MeasureTime frame
Percentage of patients with a reduction of =3 points on the Brief Fatigue Index (BFI-C) score;

Secondary

MeasureTime frame
Brief Fatigue Index (BFI-C);Generalized Anxiety Disorder Scale (GAD-7);Quality of Life Questionnaire (QLQ-C30);Blood test;Serum T lymphocyte subsets;

Countries

China

Contacts

Public ContactQian Fan
707503886@qq.com18217297588

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026